Drug Shortage Report for IMITREX
Report ID | 172797 |
Drug Identification Number | 02230418 |
Brand name | IMITREX |
Common or Proper name | Sumatriptan nasal spray |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | SUMATRIPTAN |
Strength(s) | 5MG |
Dosage form(s) | SPRAY |
Route of administration | NASAL NASAL |
Packaging size | 2s |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2022-10-28 |
Estimated end date | 2023-01-13 |
Actual end date | 2023-01-11 |
Shortage status | Resolved |
Updated date | 2023-01-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2023-01-12 | English | Compare |
v9 | 2023-01-11 | French | Compare |
v8 | 2023-01-11 | English | Compare |
v7 | 2022-12-14 | French | Compare |
v6 | 2022-12-14 | English | Compare |
v5 | 2022-11-23 | French | Compare |
v4 | 2022-11-23 | English | Compare |
v3 | 2022-10-29 | English | Compare |
v2 | 2022-10-28 | French | Compare |
v1 | 2022-10-28 | English | Compare |
Showing 1 to 10 of 10